Delaware Chapter of the American College of CardiologyOur purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments. |
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- AI-Derived Risk Score for Mortality in Secondary Mitral RegurgitationWhat is the performance of an artificial intelligence (AI)-derived risk score in predicting 1-year outcomes of patients with secondary mitral regurgitation (SMR) undergoing transcatheter edge-to-edge repair (TEER)?
- Donor Heart Acceptance by Race and Gender on Transplant WaitlistFor patients on the heart transplant waiting list, what association does race and gender have with the probability of donor heart offers being accepted?
- Secondary Mitral Regurgitation Phenotypes and M-TEER Trials: Key PointsThe following are key points to remember from a state-of-the-art review on the evolving concept of secondary mitral regurgitation (MR) phenotypes and lessons from the mitral transcatheter edge-to-edge repair (M-TEER) trials.
- Risk of Dementia During Antihypertensive Drug TherapyWhat is the effect of antihypertensive drug treatment on the risk of dementia or Alzheimer’s disease among new users of antihypertensive medications?
- Eagle’s Eye View: Sacubitril/Valsartan in Decompensated Heart Failure; Discordant Aortic Stenosis and Transcatheter Treatment of Tricuspid Valve RegurgitationIn this week’s View, Dr. Eagle looks at sacubitril/valsartan in patients hospitalized with decompensated heart failure, then examines the prevalence and outcomes of patients with discordant high gradient aortic stenosis.